{
  "title": "Special Episode: The Winding Road to Herd Immunity",
  "description": "<p>Chief Cross-Asset Strategist Andrew Sheets talks with Biotech equity analyst Matthew Harrison on dose availability, vaccine hesitancy and the timeline for herd immunity.</p>",
  "itunes:title": "Special Episode: The Winding Road to Herd Immunity",
  "itunes:episodeType": "full",
  "itunes:episode": 325,
  "itunes:summary": "Chief Cross-Asset Strategist Andrew Sheets talks with Biotech equity analyst Matthew Harrison on dose availability, vaccine hesitancy and the timeline for herd immunity.",
  "content:encoded": "<p>Chief Cross-Asset Strategist Andrew Sheets talks with Biotech equity analyst Matthew Harrison on dose availability, vaccine hesitancy and the timeline for herd immunity.</p>",
  "guid": "gid://art19-episode-locator/V0/dAAw-Lnxdzsg9WGOL_2bpgNmBuXmvk_3ThiGi4jTS2A",
  "pubDate": "Thu, 18 Mar 2021 21:07:38 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:09:06",
  "enclosure": ""
}